Search results
Viridian Therapeutics to begin Phase III trials of thyroid eye disease treatment
Clinical Trials Arena via Yahoo Finance· 14 hours agoUS-based biotechnology company Viridian Therapeutics has announced plans to begin two Phase III...
Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
Zacks via Yahoo Finance· 10 hours agoViridian (VRDN) intends to initiate two late-stage studies on its experimental thyroid eye disease...
How Long Should I Stay on Ozempic For Weight Loss?
MediaFeed via AOL· 5 days agoYou know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid answer to this question yet.
Kidney disease linked to tooth loss in older women
UPI· 10 hours agoOlder women with chronic kidney disease might wind up losing so many teeth they aren't able to chew and talk effectively, a new study warns.
Viridian shares hold Buy rating on TED trial plans By Investing.com
Investing.com· 1 day agoThe firm's focus was on the upcoming pivotal development of VRDN-003, a subcutaneous treatment for ...
Decoding Amgen's Options Activity: What's the Big Picture? - Amgen (NASDAQ:AMGN)
Benzinga· 4 hours agoRecent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease< ...
Viridian shares hold as RBC maintains $35 target By Investing.com
Investing.com· 1 day agoOn Tuesday, RBC (TSX:RY) Capital maintained its positive stance on Viridian Therapeutics...
Revolutionary New Pest Control Tool Discovered by Johns Hopkins
SciTechDaily· 4 days agoA Johns Hopkins study revealed that an enzyme in fruit fly testes could hinder insect reproduction...
Viridian Therapeutics (NASDAQ:VRDN) Shares Gap Down to $12.17
ETF DAILY NEWS· 16 hours agoViridian Therapeutics, Inc. (NASDAQ:VRDN – Get Free Report)’s share price gapped down before the market opened on Monday . Viridian Therapeutics shares last traded at $11.94, with a volume of ...
Cresset Asset Management LLC Lowers Position in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 2 days agoCresset Asset Management LLC cut its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities ...